NRx Pharmaceuticals, Inc.NRXPNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank38
3Y CAGR-29.7%
5Y CAGR-7.0%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-29.7%/yr
Annual compound
5Y CAGR
-7.0%/yr
Recent deceleration
Percentile
P38
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $15.38M | -21.9% |
| 2024 | $19.70M | -28.6% |
| 2023 | $27.58M | -37.8% |
| 2022 | $44.33M | -53.4% |
| 2021 | $95.20M | +331.6% |
| 2020 | $22.06M | +2993.0% |
| 2019 | $713187.00 | - |
| 2018 | $0.00 | - |
| 2017 | $0.00 | - |